Clinical Trial Update: Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating motexafin gadolinium in combination with radiation therapy for newly diagnosed glioblastoma was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED